Colgate director granted shares and options
COLGATE PALMOLIVE CO director John T. Cahill reported routine equity compensation awards.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO director John T. Cahill reported routine equity compensation awards. On May 11, 2026, he received an annual director stock grant of 2,075 shares of common stock, increasing his directly held shares to 28,216.
He also received an annual director stock option grant for 2,424 shares of common stock at a conversion price of $86.74 per share, with options vesting in equal annual installments over three years beginning on the first anniversary of the grant date and expiring on May 11, 2034. Separately, 36,357 shares are reported as held indirectly through a trust, which includes 2,019 shares previously reported as directly owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,499 shares
Grant/Award
3 txns
Insider
CAHILL JOHN T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,424 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 2,075 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,424 contracts (Direct);
Common Stock — 28,216 shares (Direct);
Common Stock — 36,357 shares (Indirect, By Trust)
Footnotes (4)
- F1. Annual director stock grant under the issuer's incentive compensation plan.
- F2. This amount includes 2,019 shares that were previously reported as directly beneficially owned.
- F3. Annual director stock option grant under the issuer's incentive compensation plan.
- F4. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Key Figures
Director stock grant: 2,075 shares
Stock options granted: 2,424 options
Option conversion price: $86.74 per share
+4 more
7 metrics
Director stock grant
2,075 shares
Annual director stock grant of common stock on May 11, 2026
Stock options granted
2,424 options
Annual director stock option grant on May 11, 2026
Option conversion price
$86.74 per share
Stock Option (Right to Buy) for 2,424 shares
Option expiration
May 11, 2034
Expiration date of stock options granted May 11, 2026
Direct holdings after grant
28,216 shares
Total Colgate common shares held directly after grant
Indirect holdings by trust
36,357 shares
Common shares held indirectly through a trust
Reclassified shares
2,019 shares
Previously reported as directly owned, now included in trust holdings
Key Terms
Annual director stock grant, Stock Option (Right to Buy), incentive compensation plan, indirect ownership, +1 more
5 terms
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan."
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
incentive compensation plan financial
"under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
indirect ownership financial
"ownership_type: indirect, nature_of_ownership: By Trust"
beneficially owned financial
"includes 2,019 shares that were previously reported as directly beneficially owned."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did John T. Cahill report at Colgate Palmolive (CL)?
John T. Cahill reported an annual director stock grant of 2,075 Colgate Palmolive common shares and an annual director stock option grant for 2,424 shares. Both awards were made under the company’s incentive compensation plan as non-cash equity compensation.
What are the terms of John T. Cahill’s new Colgate Palmolive (CL) stock options?
Cahill received stock options covering 2,424 Colgate Palmolive shares at a conversion price of $86.74 per share. The options vest in equal annual installments over three years, starting on the first anniversary of the May 11, 2026 grant date, and expire May 11, 2034.
How are John T. Cahill’s indirect Colgate Palmolive (CL) holdings structured?
Cahill’s indirect holding of 36,357 Colgate Palmolive shares is reported as held "By Trust." A footnote states this amount includes 2,019 shares that had previously been reported as directly beneficially owned, reflecting a change in how those shares are categorized.
AI-generated analysis. How Rhea-AI works. Not financial advice.
